Authors:
BEBOK Z
VENGLARIK CJ
PANCZEL Z
JILLING T
KIRK KL
SORSCHER EJ
Citation: Z. Bebok et al., ACTIVATION OF DELTA-F508 CFTR IN AN EPITHELIAL MONOLAYER, American journal of physiology. Cell physiology, 44(2), 1998, pp. 599-607
Authors:
BEBOK Z
MAZZOCHI C
KING SA
HONG JS
SORSCHER EJ
Citation: Z. Bebok et al., THE MECHANISM UNDERLYING CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR TRANSPORT FROM THE ENDOPLASMIC-RETICULUM TO THE PROTEASOME INCLUDES SEC61-BETA AND A CYTOSOLIC, DEGLYCOSYLATED INTERMEDIARY, The Journal of biological chemistry, 273(45), 1998, pp. 29873-29878
Authors:
CLANCY JP
HONG JS
BEBOK Z
KING SA
DEMOLOMBE S
BEDWELL DM
SORSCHER EJ
Citation: Jp. Clancy et al., CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR) NUCLEOTIDE-BINDING DOMAIN-1 (NBD-1) AND CFTR TRUNCATED WITHIN NBD-1 TARGET TO THE EPITHELIAL PLASMA-MEMBRANE AND INCREASE ANION PERMEABILITY, Biochemistry (Easton), 37(43), 1998, pp. 15222-15230
Authors:
BEDWELL DM
KAENJAK A
BENOS DJ
BEBOK Z
BUBIEN JK
HONG J
TOUSSON A
CLANCY JP
SORSCHER EJ
Citation: Dm. Bedwell et al., SUPPRESSION OF A CFTR PREMATURE STOP MUTATION IN A BRONCHIAL EPITHELIAL-CELL LINE, Nature medicine, 3(11), 1997, pp. 1280-1284
Citation: Jp. Clancy et al., PURIFICATION, CHARACTERIZATION, AND EXPRESSION OF CFTR NUCLEOTIDE-BINDING DOMAINS, Journal of bioenergetics and biomembranes, 29(5), 1997, pp. 475-482
Authors:
WALKER L
KULOMAA MS
BEBOK Z
PARKER WB
ALLAN P
LOGAN J
HUANG Z
REYNOLDS RC
KING S
SORSCHER EJ
Citation: L. Walker et al., DEVELOPMENT OF DRUG TARGETING BASED ON RECOMBINANT EXPRESSION OF THE CHICKEN AVIDIN GENE, Journal of drug targeting., 4(1), 1996, pp. 41
Authors:
DEMOLOMBE S
BARO I
BEBOK Z
CLANCY JP
SORSCHER EJ
THOMASSOUMARMON A
PAVIRANI A
ESCANDE D
Citation: S. Demolombe et al., A METHOD FOR THE RAPID DETECTION OF RECOMBINANT CFTR DURING GENE-THERAPY IN CYSTIC-FIBROSIS, Gene therapy, 3(8), 1996, pp. 685-694
Authors:
BEBOK Z
ABAI AM
DONG JY
KING SA
KIRK KL
BERTA G
HUGHES BW
KRAFT AS
BURGESS SW
SHAW W
FELGNER PL
SORSCHER EJ
Citation: Z. Bebok et al., EFFICIENCY OF PLASMID DELIVERY AND EXPRESSION AFTER LIPID-MEDIATED GENE-TRANSFER TO HUMAN-CELLS IN-VITRO, The Journal of pharmacology and experimental therapeutics, 279(3), 1996, pp. 1462-1469
Authors:
HASTY P
ONEAL WK
LIU KQ
MORRIS AP
BEBOK Z
SHUMYATSKY GB
JILLING T
SORSCHER EJ
BRADLEY A
BEAUDET AL
Citation: P. Hasty et al., SEVERE PHENOTYPE IN MICE WITH TERMINATION MUTATION IN EXON-2 OF CYSTIC-FIBROSIS GENE, Somatic cell and molecular genetics, 21(3), 1995, pp. 177-187
Authors:
HUGHES BW
WELLS AH
BEBOK Z
GADI VK
GARVER RI
PARKER WB
SORSCHER EJ
Citation: Bw. Hughes et al., BYSTANDER KILLING OF MELANOMA-CELLS USING THE HUMAN TYROSINASE PROMOTER TO EXPRESS THE ESCHERICHIA-COLI PURINE NUCLEOSIDE PHOSPHORYLASE GENE, Cancer research, 55(15), 1995, pp. 3339-3345
Authors:
SORSCHER EJ
LOGAN JJ
FRIZZELL RA
LYRENE RK
BEBOK Z
DONG JY
DUVALL MD
FELGNER PL
MATALON S
WALKER L
WIATRAK BJ
Citation: Ej. Sorscher et al., GENE-THERAPY FOR CYSTIC-FIBROSIS USING CATIONIC LIPOSOME-MEDIATED GENE-TRANSFER - A PHASE-I TRIAL OF SAFETY AND EFFICACY IN THE NASAL AIRWAY, Human gene therapy, 5(10), 1994, pp. 1259-1277
Citation: Z. Bebok et al., PROGNOSTIC RELEVANCE OF TRANSFORMING GROWTH-FACTOR-ALPHA (TGF-ALPHA) AND TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) DETECTED IN BREAST-CANCER TISSUES BY IMMUNOHISTOCHEMISTRY, Breast cancer research and treatment, 29(3), 1994, pp. 229-235